Literature DB >> 29303103

Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines.

Fehmi Tabak1, Cihan Yurdaydın1, Sabahattin Kaymakoğlu1, Mesut Akarsu1, Esra G Akıncı1, Hikmet Akkız1, Canan Alkım1, Ayhan H Çekin1, Nefise Ö Çuvalcı1, Kadir Demir1, Bülent Değertekin1, İlyas Dökmetaş1, Galip Ersöz1, Kenan Hizel1, Fatma Ö Kandemir1, Yusuf Önlen1, Abdullah Sonsuz1, Ebubekir Şenateş1, Selma Tosun1, Nurdan Tözün1, Ramazan Idilman1, Viral Hepatitis Guidelines Study Group2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29303103     DOI： 10.5152/tjg.2017.19

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  4 in total

1.  The impact of economic and social factors on the prevalence of hepatitis B in Turkey.

Authors:  Selma Tosun; Olgu Aygün; Hülya Özkan Özdemir; Elif Korkmaz; Durmuş Özdemir
Journal:  BMC Public Health       Date:  2018-05-22       Impact factor: 3.295

2.  Are there optimal alanine aminotransferase and HBV DNA thresholds for discriminating HBeAg-positive chronic infection from chronic hepatitis? An evaluation of 215 young and male cases.

Authors:  Ercan Yenilmez; Riza A Cetinkaya
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

3.  Outcomes of Glucocorticoid Treatment in HBVAssociated Acute-on-Chronic Liver Failure Patients: A Retrospective Observational Study.

Authors:  Yun Xu; Yongfang Jiang; Yi Li
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

4.  Two decades of research on autoimmune liver disease in Turkey.

Authors:  Nurhan Demir; Nazım Ekin; Murat Torgutalp; Staffan Wahlin; Cumali Efe
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.